يعرض 1 - 10 نتائج من 66 نتيجة بحث عن '"circulating tumour DNA"', وقت الاستعلام: 1.17s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
  4. 4
    دورية أكاديمية

    المصدر: Perakis , S O , Weber , S , Zhou , Q , Graf , R , Hojas , S , Riedl , J M , Gerger , A , Dandachi , N , Balic , M , Hoefler , G , Schuuring , E , Groen , H J M , Geigl , J B , Heitzer , E & Speicher , M R 2020 , ' Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer ' , ESMO Open , vol. 5 , no. 5 , 000872 ....

    وصف الملف: application/pdf

  5. 5
  6. 6

    المصدر: van Rees, J M, Wullaert, L, Grüter, A A J, Derraze, Y, Tanis, P J, Verheul, H M W, Martens, J W M, Wilting, S M, Vink, G, van Vugt, J L A, Beije, N & Verhoef, C 2023, ' Circulating tumour DNA as biomarker for rectal cancer : A systematic review and meta-analyses ', Frontiers in Oncology, vol. 13, 1083285 . https://doi.org/10.3389/fonc.2023.1083285Test

  7. 7
  8. 8

    المصدر: Molecular Oncology
    Lyskjær, I, Davies, C, Strobl, A C, Hindley, J, James, S, Lalam, R K, Cross, W, Hide, G, Rankin, K S, Jeys, L, Tirabosco, R, Stevenson, J, O’Donnell, P, Cool, P, Flanagan, A M & Genomics England Research Consortium 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102Test
    Molecular Oncology, Vol 15, Iss 12, Pp 3679-3690 (2021)
    Lyskjær, I 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102Test

    وصف الملف: application/pdf

  9. 9

    المصدر: Henriksen, T V, Reinert, T, Rasmussen, M H, Demuth, C, Løve, U S, Madsen, A H, Gotschalck, K A, Iversen, L H & Andersen, C L 2022, ' Comparing single-target and multitarget approaches for postoperative circulating tumour DNA detection in stage II-III colorectal cancer patients ', Molecular Oncology, vol. 16, no. 20, pp. 3654-3665 . https://doi.org/10.1002/1878-0261.13294Test

  10. 10

    المساهمون: Institut Català de la Salut, [Pascual J] Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Malaga, Spain. [Attard G] Urological Cancer Research, University College London, London, UK. [Bidard FC] Department of Medical Oncology, Institut Curie, Paris, France. University of Versailles Saint-Quentin-en-Yvelines (UVSQ)/Paris-Saclay University, Saint Cloud, France. [Curigliano G] Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy. [De Mattos-Arruda L] IrsiCaixa, Hospital Universitari Trias i Pujol, Badalona, Spain. Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. [Diehn M] Department of Radiation Oncology, Stanford University School of Medicine, Stanford, USA. [Seoane J] Preclinical and Translational Research Programme, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. ICREA, CIBERONC, Barcelona, Spain. Medical School, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; image/jpeg